Results 31 to 40 of about 975 (104)

European Journal of Heart Failure expert consensus statement on transcatheter treatment of mitral regurgitation in heart failure

open access: yesEuropean Journal of Heart Failure, Volume 27, Issue 11, Page 2610-2622, November 2025.
The patient with SMR: From diagnostic assessment to treatment. Secondary mitral regurgitation (SMR) is highly prevalent in patients with heart failure (HF), associated with poor prognosis, and its treatment is typically preceded by implementing pharmacotherapy for HF as well as cardiac resynchronization therapy.
Christos Iliadis   +11 more
wiley   +1 more source

Rationale and design of the TRIC‐I‐HF‐DZHK24 (TRICuspid Intervention in Heart Failure) trial

open access: yesEuropean Journal of Heart Failure, Volume 27, Issue 10, Page 1895-1904, October 2025.
Study overview of the TRIC‐I‐HF‐DZHK24 trial. HF, heart failure; HFH, heart failure hospitalization; QoL, quality of life; RHC, right heart catheterization; TR, tricuspid regurgitation; TTVI, transcatheter tricuspid valve intervention. Abstract Aims Tricuspid regurgitation (TR) is a detrimental disease frequently diagnosed in patients with right‐sided ...
Thomas J. Stocker   +110 more
wiley   +1 more source

Evaluation of the Remodeling of the Tricuspid Annulus and Right Heart in Persistent Atrial Fibrillation Patients With or Without Radiofrequency Ablation via Three‐Dimensional Echocardiography

open access: yesEchocardiography, Volume 42, Issue 10, October 2025.
Three‐dimensional echocardiography (3DE) for evaluating the reverse remodeling of tricuspid annulus (TA) and right heart (RH) in persistent atrial fibrillation (AF) with radiofrequency ablation (RFA). ABSTRACT Background Atrial fibrillation (AF) is linked to tricuspid annulus (TA) and right heart (RH) remodeling.
Yuan Tian   +8 more
wiley   +1 more source

Risk Stratification Using Mitral INsufficiency Echocardiographic Score 2 in Dogs With Preclinical Mitral Valve Disease

open access: yesJournal of Veterinary Internal Medicine, Volume 39, Issue 5, September/October 2025.
ABSTRACT Background Outcome‐based cardiac risk stratification schemes are lacking for preclinical myxomatous mitral valve disease (MMVD). The Mitral INsufficiency Echocardiographic (MINE) score was developed as an easy‐to‐use severity classification of MMVD.
Tommaso Vezzosi   +13 more
wiley   +1 more source

Dapagliflozin effect on functional mitral regurgitation and myocardial remodelling: The DEFORM trial

open access: yesESC Heart Failure, Volume 12, Issue 4, Page 2866-2877, August 2025.
Abstract Aims Functional mitral regurgitation (FMR) is associated with adverse outcomes in patients with heart failure, and current guideline‐directed medical therapy (GDMT) offers limited efficacy in managing FMR. This study aims to evaluate the therapeutic impact of the sodium‐glucose cotransporter 2 inhibitor (SGLT2i) dapagliflozin in patients with ...
Zhuoshan Huang   +18 more
wiley   +1 more source

Right atrial remodelling and prognosis in patients with severe atrial functional tricuspid regurgitation

open access: yesESC Heart Failure, Volume 12, Issue 4, Page 2909-2920, August 2025.
Abstract Aims Atrial functional tricuspid regurgitation (AFTR) is increasingly recognized as a distinct cause of tricuspid regurgitation, yet data on outcomes and their determinants are limited. This study examines the prognostic role of right atrial (RA) remodelling in patients with severe AFTR.
Soongu Kwak   +8 more
wiley   +1 more source

Aetiological phenotypes of atrial and ventricular secondary tricuspid regurgitation and their prognostic implications: insights from the CARE‐TR registry

open access: yesEuropean Journal of Heart Failure, Volume 27, Issue 8, Page 1549-1558, August 2025.
Aetiological phenotypes of secondary tricuspid regurgitation. AF, atrial fibrillation; HFpE, heart failure with preserved ejection fraction; CARE‐TR, Consecutive pAtients with seveRE Tricuspid Regurgitation evaluated in Heart Failure and Valve Clinics; HF, heart failure; HFmrEF, heart failure with mildly reduced ejection fraction; HFrEF, heart failure ...
Laura Lupi   +17 more
wiley   +1 more source

Transcatheter edge‐to‐edge repair of atrial secondary mitral regurgitation positively influences atrial remodelling

open access: yesESC Heart Failure, Volume 12, Issue 3, Page 2267-2277, June 2025.
Abstract Background Atrial secondary mitral valve regurgitation (ASMR) is a distinct anatomical subset of secondary mitral regurgitation (SMR). Evidence of the effect of transcatheter edge‐to‐edge repair (TEER) on left atrial (LA) anatomy and function, especially reverse remodelling (LARR), is still sparse.
Aniela Petrescu   +10 more
wiley   +1 more source

Functional Mitral Valve Regurgitation, Pathophysiology, Leaflet ReModeling, and the Role of Imaging

open access: yesEchocardiography, Volume 42, Issue 3, March 2025.
Functional mitral regurgitation (FMR) is a complex left ventricle (LV) and left atrium (LA) disorder with a multifactorial etiology. Regional and global LV dysfunction, extent and location of fibrotic myocardium and annulus enlargement are the leading causes of valve regurgitation.
Francesco Fulvio Faletra   +9 more
wiley   +1 more source

Impact of Right Ventricular to Pulmonary Artery Coupling on Survival Following Indirect Mitral Annuloplasty

open access: yesCatheterization and Cardiovascular Interventions, Volume 105, Issue 3, Page 566-576, February 15, 2025.
ABSTRACT Background Right ventricular‐to‐pulmonary artery (RV‐PA) coupling is an important predictor of long‐term survival following transcatheter edge‐to‐edge repair. However, its impact on survival in patients undergoing indirect mitral annuloplasty is unknown.
Dennis Rottländer   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy